TrialEuropean journal of neurology2026

Long-Term Improvements Following Initial Migraine Response in Eptinezumab-Treated Participants With Migraine for Whom 2-4 Prior Preventive Treatments Have Failed.

Jessica Ailani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.